Skip to main content
GutCited

Galactooligosaccharides (GOS) के लिए Irritable Bowel Syndrome (IBS)

B

Reduces IBS symptoms (pain, bloating, flatulence) in dose-dependent manner. 3.5 g/day showed better results than 7 g/day (excess fermentation at higher dose).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dgalactooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

Reduces IBS symptoms (pain, bloating, flatulence) in dose-dependent manner. 3.5 g/day showed better results than 7 g/day (excess fermentation at higher dose).

Key Study Findings

Review
Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: review of prebiotics, probiotics, synbiotics, postbiotics for gastrointestinal inflammation

Randomized Controlled Trial n=45 12 weeks Double-blind
All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable …
Dose: None बनाम: Sequential FODMAP subgroup reintroduction Outcome: Abdominal pain and bloating severity प्रभाव: None p=0.007 fructans; p=0.04 GOS

जनसंख्या: IBS patients (Rome IV) who improved on FODMAP diet

Randomized Controlled Trial 4 weeks Double-blind
Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized …
Dose: None बनाम: Traditional low FODMAP diet Outcome: IBS symptom response प्रभाव: None None

जनसंख्या: IBS-D patients (Rome IV)

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None बनाम: Various Outcome: IBS symptom improvement प्रभाव: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

जनसंख्या: Adult IBS patients

Randomized Controlled Trial n=34 8 weeks Single-blind
A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation …
Dose: 9.2 g/day total (4.6 g twice daily) बनाम: Maltodextrin 9.2 g/day placebo Outcome: IBS-SSS score and IBS-QoL score प्रभाव: IBS-SSS: 267.3→195.8; IBS-QoL: 61.0→77.4 0.026 (IBS-SSS); 0.006 (QoL)

जनसंख्या: Adults with constipation-predominant IBS

Other
Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.
Dose: None बनाम: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers प्रभाव: Up to 99.5% FODMAP reduction (wheat malt) None

जनसंख्या: Laboratory food science study (no human subjects)

Key Statistics

3

अध्ययन

400

प्रतिभागी

Positive

B

ग्रेड

Referenced Papers

Foods (Basel, Switzerland) 2025 3 उद्धरण
Archivos argentinos de … 2024 3 उद्धरण
Carbohydrate polymers 2022 77 उद्धरण
Expert review of … 2022 8 उद्धरण
Frontline gastroenterology 2021 56 उद्धरण
Current opinion in … 2021 6 उद्धरण
Critical reviews in … 2019 35 उद्धरण
Foods (Basel, Switzerland) 2019 21 उद्धरण
The American journal … 2019 15 उद्धरण
Journal of gastroenterology … 2017 181 उद्धरण
International journal of … 2017 146 उद्धरण
Journal of gastroenterology … 2017 32 उद्धरण
Current opinion in … 2017 24 उद्धरण
World journal of … 2016 238 उद्धरण
Scandinavian journal of … 2016 17 उद्धरण
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2016 2 उद्धरण
Journal of neurogastroenterology … 2015 60 उद्धरण
Menopause international 2009 29 उद्धरण
Alimentary pharmacology & … 2006 629 उद्धरण
The British journal … 2001 166 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
2.5-5 g/day
ibssupport:
3.5 g/day (optimal dose; higher doses may increase symptoms)
infantgutsupport:
0.24-0.48 g/100 mL formula (added to infant formula)

अधिकतम सीमा: Well-tolerated up to 15 g/day; optimal dose appears to be 3.5-5 g/day

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Positive --
None 12 weeks Negative 45
None 4 weeks Mixed --
None -- Positive --
9.2 g/day total (4.6 g twice daily) 8 weeks Positive 34
None -- Positive --
1e9 CFU/day + GOS 10 g/L -- Positive --
None -- Neutral --

सेवन का सर्वोत्तम समय: With meals; start with lower dose and increase gradually

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Gas and bloating (especially above 5 g/day; dose-response is U-shaped)
  • Flatulence at higher doses
  • Abdominal cramping if dose increased too quickly
  • May worsen symptoms in FODMAP-sensitive individuals

ज्ञात अंतःक्रियाएँ

  • Other FODMAPs (cumulative fermentation in sensitive individuals)
  • Lactose-containing products (GOS is derived from lactose; generally safe for lactose-intolerant individuals as GOS itself is lactose-free)

सहनीय अधिकतम सेवन: Well-tolerated up to 15 g/day; optimal dose appears to be 3.5-5 g/day

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Galactooligosaccharides (GOS) help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Galactooligosaccharides (GOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Galactooligosaccharides (GOS) should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 2.5-5 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Galactooligosaccharides (GOS)?
Reported side effects may include Gas and bloating (especially above 5 g/day; dose-response is U-shaped), Flatulence at higher doses, Abdominal cramping if dose increased too quickly, May worsen symptoms in FODMAP-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Galactooligosaccharides (GOS) and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।